AwardedPOLGoods
Sukcesywne dostawy leku Pemazyre do nowego programu lekowego B.5 dla SPZOZ Opolskie Centrum Onkologii w Opolu
- Published
- Published 12 May 2026
Overview
The Opolskie Centrum Onkologii in Opolu has awarded a contract for successive deliveries of Pemazyre pharmaceutical product for a new drug program B.5. The contract, valued at 2,252,606 PLN, was awarded on 20 May 2026 to Komtur Polska Sp. z o.o., with specific quantities and product types defined in the procurement documentation.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 12 May 2026
Pharmaceutical products
Award outcome
- Awarded value
- PLN 2,252,606
- Award date
- 20 May 2026
- Contract period
- 20 May 2026 → 15 May 2027
- Komtur Polska Sp. z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
22 May 2026
Contract Notice
11 May 2026
Contracting authority
Samodzielny Publiczny Zakład Opieki Zdrowotnej Opolskie Centrum Onkologii im. prof. Tadeusza Koszarowskiego w Opolu
Procuring entityOpole, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.